135 related articles for article (PubMed ID: 12924092)
1. [Development of a live culture of cold-adapted reassortant influenza vaccines].
Gendon IuZ; Markushin SG; Akopova II; Koptiaeva NB; Isachenko AA; Mazurkova NA; Nechaeva EA
Vopr Virusol; 2003; 48(2):12-7. PubMed ID: 12924092
[TBL] [Abstract][Full Text] [Related]
2. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.
Ghendon YZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova LA; Radaeva IF; Kolokoltseva TD
Vaccine; 2005 Sep; 23(38):4678-84. PubMed ID: 16026905
[TBL] [Abstract][Full Text] [Related]
3. Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses.
Romanova JR; Tannock GA; Alexandrova GI
Vaccine; 1997; 15(6-7):653-8. PubMed ID: 9178466
[TBL] [Abstract][Full Text] [Related]
4. Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.
Kiseleva I; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rudenko L; Shaw AR; Youil R
J Virol Methods; 2004 Mar; 116(1):71-8. PubMed ID: 14715309
[TBL] [Abstract][Full Text] [Related]
5. [Further development (MDCK) of live cold-adapted influenza vaccine: cultivation of vaccine strains in production fermenters].
Gendon IuZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova IA; Radaeva IF; Kolokol'tsova TD
Vopr Virusol; 2005; 50(2):4-9. PubMed ID: 15881389
[TBL] [Abstract][Full Text] [Related]
6. Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice.
Romanova JR; Ermachenko TA; Alexandrova GI; Tannock GA
Vaccine; 1994 Jan; 12(1):23-7. PubMed ID: 8303936
[TBL] [Abstract][Full Text] [Related]
7. [The effect of different factors on the reproduction of influenza viruses and reassortants in cell cultures].
Podcherniaeva RIa; Danlybaeva GA
Vopr Virusol; 1991; 36(5):384-6. PubMed ID: 1803770
[TBL] [Abstract][Full Text] [Related]
8. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of a live attenuated influenza B virus vaccine candidate.
Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
[TBL] [Abstract][Full Text] [Related]
11. [The reproduction of reassortant influenza A and B viruses with a known genome composition in different cell systems].
Klimov AI; Podcherniaeva RIa; Danlybaeva GA; Iaros VV; Lisovskaia KV
Vopr Virusol; 1992; 37(1):31-7. PubMed ID: 1413710
[TBL] [Abstract][Full Text] [Related]
12. [Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium].
Podcherniaeva RIa; Baklanova OV; Glushchenko LA; Isaeva EI; Chestkov VV; Tabakov VIu; Mikhaĭlova GR
Vopr Virusol; 2010; 55(5):47-9. PubMed ID: 21260998
[TBL] [Abstract][Full Text] [Related]
13. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
14. The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees.
Abbasi S; Gruber W; Edwards K; Gubareva L; Webster RG; Kawaoka Y
Virus Res; 1995 Dec; 39(2-3):377-83. PubMed ID: 8837899
[TBL] [Abstract][Full Text] [Related]
15. [Restriction analysis of genome composition of live influenza vaccine].
Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells].
Kiseleva IV; Isakova IN; Larionova NV; Oleĭnik ES; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):40-5. PubMed ID: 18283733
[TBL] [Abstract][Full Text] [Related]
17. Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.
Rekstin AR; Kiseleva IV; Klimov AI; Katz JM; Rudenko LG
Vaccine; 2006 Nov; 24(44-46):6581-4. PubMed ID: 16857302
[No Abstract] [Full Text] [Related]
18. [Local immune response to live cold-adapted reassortant influenza vaccine in children, adults, and aged people].
Donina SA; Naĭkhin AN; Grigor'eva EP; Desheva IuA; Barantseva IB; Rekstin AR; Rudenko LG
Vopr Virusol; 2003; 48(2):29-31. PubMed ID: 12924096
[TBL] [Abstract][Full Text] [Related]
19. The use of components of plant origin in the development of production technology for live cold-adapted cultural influenza vaccine.
Mazurkova NA; Kolokol'tsova TD; Nechaeva EA; Shishkina LN; Sergeev AN
Bull Exp Biol Med; 2008 Jul; 146(1):144-7. PubMed ID: 19145373
[TBL] [Abstract][Full Text] [Related]
20. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
